5 Stocks Tumbling Today

4. Bristol-Myers Squibb Company (NYSE:BMY) is down 3.37% as of 10:36 AM ET after the New York-based pharmaceutical company trimmed its FY22 EPS outlook. Bristol-Myers Squibb Company (NYSE:BMY) lowered its non-GAAP EPS prior estimate of $7.65 – $7.95 to $7.44 – $7.74. At the midpoint of $7.59, it falls 15 cents short of the consensus estimate of $7.74. Moreover, Bristol-Myers Squibb Company (NYSE:BMY) also slashed the full-year guidance for its blood cancer drug Revlimid by $500 million.

Of the 924 hedge funds in Insider Monkey’s database, Bristol-Myers Squibb Company (NYSE:BMY) was held by 66 hedge funds as of Q4 2021.